$AIRG
AIRGAIN INC

2023 Q3 Form 10-Q Financial Statement

#000095017023041464 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $13.70M $15.83M
YoY Change -28.66% -17.92%
Cost Of Revenue $8.460M $9.551M
YoY Change -28.03% -19.01%
Gross Profit $5.236M $6.279M
YoY Change -29.65% -16.2%
Gross Profit Margin 38.23% 39.67%
Selling, General & Admin $4.848M $5.901M
YoY Change -16.5% -3.96%
% of Gross Profit 92.59% 93.98%
Research & Development $2.298M $2.590M
YoY Change -20.79% -12.56%
% of Gross Profit 43.89% 41.25%
Depreciation & Amortization $200.0K $200.0K
YoY Change 0.0% 0.0%
% of Gross Profit 3.82% 3.19%
Operating Expenses $7.146M $8.491M
YoY Change -17.93% -6.75%
Operating Profit -$1.910M -$2.212M
YoY Change 51.11% 37.14%
Interest Expense $30.00K $16.00K
YoY Change 15.38% 166.67%
% of Operating Profit
Other Income/Expense, Net $33.00K -$5.000K
YoY Change -294.12% -44.44%
Pretax Income -$1.877M -$2.207M
YoY Change 50.52% 36.07%
Income Tax $4.000K $2.000K
% Of Pretax Income
Net Earnings -$1.881M -$2.205M
YoY Change 44.8% 36.2%
Net Earnings / Revenue -13.73% -13.93%
Basic Earnings Per Share -$0.18 -$0.21
Diluted Earnings Per Share -$0.18 -$0.21
COMMON SHARES
Basic Shares Outstanding 10.42M 10.41M
Diluted Shares Outstanding 10.43M 10.41M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.990M $9.270M
YoY Change 8.71% -1.88%
Cash & Equivalents $9.989M $9.270M
Short-Term Investments
Other Short-Term Assets $2.040M $1.688M
YoY Change 1.75% -7.51%
Inventory $3.950M $4.797M
Prepaid Expenses
Receivables $6.272M $8.626M
Other Receivables $0.00 $0.00
Total Short-Term Assets $22.25M $24.38M
YoY Change -25.81% -17.95%
LONG-TERM ASSETS
Property, Plant & Equipment $2.454M $2.544M
YoY Change -12.86% -13.79%
Goodwill $10.85M $10.85M
YoY Change 0.0% 0.0%
Intangibles $8.977M $9.718M
YoY Change -24.94% -23.58%
Long-Term Investments
YoY Change
Other Assets $170.0K $210.0K
YoY Change -30.04% -24.19%
Total Long-Term Assets $24.05M $25.13M
YoY Change -15.02% -14.31%
TOTAL ASSETS
Total Short-Term Assets $22.25M $24.38M
Total Long-Term Assets $24.05M $25.13M
Total Assets $46.30M $49.51M
YoY Change -20.57% -16.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.425M $5.659M
YoY Change -30.69% -19.87%
Accrued Expenses $3.750M $2.027M
YoY Change -34.88% -39.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.514M $11.21M
YoY Change -33.78% -23.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $880.0K $1.080M
YoY Change -50.62% -44.24%
Total Long-Term Liabilities $880.0K $1.080M
YoY Change -50.62% -44.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.514M $11.21M
Total Long-Term Liabilities $880.0K $1.080M
Total Liabilities $10.54M $12.43M
YoY Change -35.28% -25.98%
SHAREHOLDERS EQUITY
Retained Earnings -$73.04M -$71.16M
YoY Change 16.17% 15.56%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.364M $5.364M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $35.77M $37.08M
YoY Change
Total Liabilities & Shareholders Equity $46.30M $49.51M
YoY Change -20.57% -16.15%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$1.881M -$2.205M
YoY Change 44.8% 36.2%
Depreciation, Depletion And Amortization $200.0K $200.0K
YoY Change 0.0% 0.0%
Cash From Operating Activities $640.0K -$570.0K
YoY Change 521.36% -73.76%
INVESTING ACTIVITIES
Capital Expenditures $70.00K $15.00K
YoY Change -115.22% -132.61%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$70.00K -$15.00K
YoY Change -84.78% -58.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 70.00K 16.00K
YoY Change -29.29% -100.23%
NET CHANGE
Cash From Operating Activities 640.0K -570.0K
Cash From Investing Activities -70.00K -15.00K
Cash From Financing Activities 70.00K 16.00K
Net Change In Cash 640.0K -569.0K
YoY Change -348.06% -93.82%
FREE CASH FLOW
Cash From Operating Activities $640.0K -$570.0K
Capital Expenditures $70.00K $15.00K
Free Cash Flow $570.0K -$585.0K
YoY Change 1.24% -72.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001272842
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2025-12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37851
dei Entity Registrant Name
EntityRegistrantName
AIRGAIN, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4523882
dei Entity Address Address Line1
EntityAddressAddressLine1
3611 Valley Centre Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
dei City Area Code
CityAreaCode
760
dei Local Phone Number
LocalPhoneNumber
579-0200
dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
AIRG
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10423964
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9270000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11903000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8626000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8741000
CY2023Q2 us-gaap Inventory Net
InventoryNet
4797000
CY2022Q4 us-gaap Inventory Net
InventoryNet
4226000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1688000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2284000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
24381000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
27154000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2544000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2765000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1814000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2217000
CY2023Q2 us-gaap Goodwill
Goodwill
10845000
CY2022Q4 us-gaap Goodwill
Goodwill
10845000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9718000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11203000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
210000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
216000
CY2023Q2 us-gaap Assets
Assets
49512000
CY2022Q4 us-gaap Assets
Assets
54400000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5659000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6507000
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1100000
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2874000
CY2023Q2 airg Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
3527000
CY2022Q4 airg Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
2615000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
921000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
904000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11207000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12900000
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
146000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
139000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1080000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1536000
CY2023Q2 us-gaap Liabilities
Liabilities
12433000
CY2022Q4 us-gaap Liabilities
Liabilities
14575000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10964000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10423000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10767000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10226000
CY2023Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
113599000
CY2022Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
111282000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
5364000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5364000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71156000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66093000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
37079000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
39825000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49512000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54400000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15830000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19286000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32274000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36808000
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
9551000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
11793000
us-gaap Cost Of Revenue
CostOfRevenue
19677000
us-gaap Cost Of Revenue
CostOfRevenue
22159000
CY2023Q2 us-gaap Gross Profit
GrossProfit
6279000
CY2022Q2 us-gaap Gross Profit
GrossProfit
7493000
us-gaap Gross Profit
GrossProfit
12597000
us-gaap Gross Profit
GrossProfit
14649000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2590000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2962000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5039000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6204000
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2305000
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2889000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5171000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5744000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3596000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3255000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7389000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6740000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
8491000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
9106000
us-gaap Operating Expenses
OperatingExpenses
17599000
us-gaap Operating Expenses
OperatingExpenses
18688000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2212000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1613000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5002000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4039000
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
16000
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
34000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
11000
CY2023Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
11000
CY2022Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
15000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
15000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
30000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2207000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1622000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4983000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4058000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
80000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2205000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1619000
us-gaap Net Income Loss
NetIncomeLoss
-5063000
us-gaap Net Income Loss
NetIncomeLoss
-4140000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10413000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10219000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10340000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10188000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10413000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10219000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10340000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10188000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2205000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1619000
us-gaap Net Income Loss
NetIncomeLoss
-5063000
us-gaap Net Income Loss
NetIncomeLoss
-4140000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2205000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1619000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5063000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4140000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
38300000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
42823000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6879000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
39825000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44173000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
37079000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
42248000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
37079000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
42248000
us-gaap Profit Loss
ProfitLoss
-5063000
us-gaap Profit Loss
ProfitLoss
-4140000
us-gaap Depreciation
Depreciation
342000
us-gaap Depreciation
Depreciation
337000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-11000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1485000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1513000
us-gaap Share Based Compensation
ShareBasedCompensation
1949000
us-gaap Share Based Compensation
ShareBasedCompensation
2455000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-115000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-935000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
571000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-328000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-596000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
554000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-6000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-75000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-877000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1159000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-880000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-193000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
912000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
94000
airg Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-36000
airg Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-50000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2004000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1980000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
104000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
174000
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
10000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-164000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7015000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
690000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
165000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
136000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-525000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2633000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5063000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12078000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14686000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9445000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9623000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
64000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
110000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
254000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
29000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
429000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9270000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9448000
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
175000
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
175000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9445000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9623000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements.</span></p>
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
100000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
200000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2205000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1619000
us-gaap Net Income Loss
NetIncomeLoss
-5063000
us-gaap Net Income Loss
NetIncomeLoss
-4140000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10413000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10219000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10340000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10188000
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10413000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10219000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10340000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10188000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2413000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2122000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2369000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2032000
CY2023Q2 us-gaap Cash
Cash
9249000
CY2023Q2 us-gaap Cash
Cash
9249000
CY2023Q2 us-gaap Cash
Cash
9249000
CY2023Q2 airg Cash And Cash Equivalents At Carrying Value Available And Available For Sale Debt Securities Amortized Cost Basis
CashAndCashEquivalentsAtCarryingValueAvailableAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
9270000
CY2023Q2 airg Cash And Cash Equivalents At Carrying Value Available And Available For Sale Debt Securities Amortized Cost Basis
CashAndCashEquivalentsAtCarryingValueAvailableAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
9270000
CY2023Q2 airg Cash And Cash Equivalents At Carrying Value Available And Available For Sale Debt Securities Amortized Cost Basis
CashAndCashEquivalentsAtCarryingValueAvailableAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
9270000
CY2022Q4 us-gaap Cash
Cash
8323000
CY2022Q4 us-gaap Cash
Cash
8323000
CY2022Q4 us-gaap Cash
Cash
8323000
CY2022Q4 airg Cash And Cash Equivalents At Carrying Value Available And Available For Sale Debt Securities Amortized Cost Basis
CashAndCashEquivalentsAtCarryingValueAvailableAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
11903000
CY2022Q4 airg Cash And Cash Equivalents At Carrying Value Available And Available For Sale Debt Securities Amortized Cost Basis
CashAndCashEquivalentsAtCarryingValueAvailableAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
11903000
CY2022Q4 airg Cash And Cash Equivalents At Carrying Value Available And Available For Sale Debt Securities Amortized Cost Basis
CashAndCashEquivalentsAtCarryingValueAvailableAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
11903000
CY2023Q2 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
175000
CY2022Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
175000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
80000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
80000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
95000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
95000
CY2023Q2 airg Provision For Excess And Obsolete Inventories
ProvisionForExcessAndObsoleteInventories
1000000
CY2022Q4 airg Provision For Excess And Obsolete Inventories
ProvisionForExcessAndObsoleteInventories
900000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7275000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7170000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4731000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4405000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2544000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2765000
CY2023Q2 us-gaap Depreciation
Depreciation
200000
CY2022Q2 us-gaap Depreciation
Depreciation
200000
us-gaap Depreciation
Depreciation
300000
us-gaap Depreciation
Depreciation
300000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20095000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10377000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9718000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20095000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8892000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11203000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1484000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2968000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2958000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
557000
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
356000
CY2023Q2 airg Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
1395000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9718000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500000
CY2023Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022Q2 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1003000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
815000
CY2023Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
339000
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
339000
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
197000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
166000
CY2023Q2 airg Advanced Payments From Contract Manufacturers
AdvancedPaymentsFromContractManufacturers
148000
CY2022Q4 airg Advanced Payments From Contract Manufacturers
AdvancedPaymentsFromContractManufacturers
210000
CY2023Q2 airg Contract Liabilities Current
ContractLiabilitiesCurrent
0
CY2022Q4 airg Contract Liabilities Current
ContractLiabilitiesCurrent
32000
CY2023Q2 airg Goods Received Not Invoiced
GoodsReceivedNotInvoiced
1702000
CY2022Q4 airg Goods Received Not Invoiced
GoodsReceivedNotInvoiced
529000
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
138000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
524000
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3527000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2615000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
5 years
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
27000
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
42000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
200000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
200000
us-gaap Operating Lease Cost
OperatingLeaseCost
500000
us-gaap Operating Lease Cost
OperatingLeaseCost
500000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
498000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
902000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
687000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2087000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
88000
CY2023Q2 airg Unrealized Translation Gain
UnrealizedTranslationGain
2000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2001000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
921000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1080000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.016
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.02
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11900000
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4030000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32274000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36808000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15830000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19286000
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3825000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
968000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1214000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1949000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2455000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2065000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.78
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
758000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
267000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.71
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.3
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
40000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
191000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.08
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2129000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.95
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M24D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
608000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1491000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
11.45
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y3M18D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
541000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2129000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.95
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y4M24D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
608000
CY2022Q4 airg Severance And Exit Costs1
SeveranceAndExitCosts1
0
CY2023Q1 airg Accrued Expense Of Severanc Costs
AccruedExpenseOfSeverancCosts
205000
CY2023Q1 airg Payment Of Severance Costs
PaymentOfSeveranceCosts
-92000
CY2023Q1 airg Severance And Exit Costs1
SeveranceAndExitCosts1
113000
CY2023Q2 airg Accrued Expense Of Severanc Costs
AccruedExpenseOfSeverancCosts
365000
CY2023Q2 airg Payment Of Severance Costs
PaymentOfSeveranceCosts
-71000
CY2023Q2 airg Severance And Exit Costs1
SeveranceAndExitCosts1
407000
airg Accrual Warranty Expense
AccrualWarrantyExpense
100000
CY2022 airg Accrual Warranty Expense
AccrualWarrantyExpense
200000
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
2544000
CY2022Q4 us-gaap Noncurrent Assets
NoncurrentAssets
2765000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15830000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19286000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
32274000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36808000

Files In Submission

Name View Source Status
0000950170-23-041464-index-headers.html Edgar Link pending
0000950170-23-041464-index.html Edgar Link pending
0000950170-23-041464.txt Edgar Link pending
0000950170-23-041464-xbrl.zip Edgar Link pending
airg-20230630.htm Edgar Link pending
airg-20230630.xsd Edgar Link pending
airg-ex10_1.htm Edgar Link pending
airg-ex31_1.htm Edgar Link pending
airg-ex31_2.htm Edgar Link pending
airg-ex32_1.htm Edgar Link pending
airg-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
airg-20230630_cal.xml Edgar Link unprocessable
airg-20230630_def.xml Edgar Link unprocessable
airg-20230630_lab.xml Edgar Link unprocessable
airg-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
airg-20230630_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending